Summary
The prevalence and pattern of psychotropic drug use was investigated in an urban walk-in clinic in Nigeria during the course of a two-stage epidemiological survey. A total of 14.9% of the patients were using psychotropic drugs, with almost all the users taking anxiolytics. There was no significant sex difference in the prevalence of drug taking. Almost half of the users had been on the drug for over 12 months. Increasing age was associated with psychotropic drug taking in females while being married had a similar association in males. While increasing score on the GHQ-12 was associated with drug taking, over two-thirds of patients with DSM-IIIR disorders identified during the second-stage interview were not taking any psychotropic drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cafferata GL, Kasper J, Bernstein A (1983) Family roles, structure and stressors in relation to sex differences in obtaining psychotropic drugs. J Health Soc Behav 24: 132–143
Cooperstock R (1971) Sex differences in the use of mood modifying drugs: an explanatory model. J Health Soc Behav 12: 238–244
Goldberg DP (1972) The detection of psychiatric illness by questionnaire. Maudsley Monograph No. 21 Oxford University Press, Oxford
Goodchild ME, Duncan-Jones P (1985) Chronicity and the General Health Questionnaire. Br J Psychiatry 146: 55–61
Gureje O, Obikoya B (1990) The GHQ-12 as a screening tool in a primary care setting. Soc Psychiatry Psychiatr Epidemiol 25: 276–280
Harris G, Latham J, McGuinness B et al. (1977) The relationship between psychoneurotic states and psychoactive drug prescription in general practice. R Coll Gen Pract 27: 173–177
Murray J, Dunn G, Williams P et al. (1981) Factors affecting the consumption of psychotropic drugs. Psychol Med 11: 551–560
Murray J, Williams P, Clare AW (1982) Health and social characteristics of long-term psychotropic drug takers. Soc Sci Med 16: 1595–1598
Semler G, Wittchen HU, Joschke K, Zaudig M, Geiso T Kaiser S, Cranach M von, Pfister H (1987) Test-retest reliability of a standardized psychiatric interview (DIS/CIDI) for DSM-III diagnoses. Eur Arch Psychiatr Neurol Sci 236:214–222
Skegg DCG, Doll R, Perry J (1977) Use of medicine in general practice. Br Med J 1: 1561–1563
Vazquez-Barquero JL, Manrique JF, Pena C, Gonzalez AA, Cuesta MJ, Artal JA (1989) Patterns of psychotropic drug use in a Spanish rural community. Br J Psychiatry 155: 633–641
World Health Organization-Alcohol, Drug, and Mental Health Administration (1987) Composite International Diagnostic Interview. World Health Organization, Geneva
Williams P (1978) Physical ill-health and psychotropic drug prescription: a review. Psychol Med 8: 683–693
Williams P, Gabe J (1989) Tranquillizer use: epidemiological and sociological aspects. In: Williams P, Wilkinson G, Rawnsley K (eds). The scope of epidemiological psychiatry. Routledge, London, pp 328–342
Wittchen HU, Burke JD, Semler G, Pfister H, Cranach M von, Zaudig M (1989) Recall and dating of psychiatric symptoms. Arch Gen Psychiatry 46: 437–443
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gureje, O., Obikoya, B. Psychotropic drug use in an urban primary care clinic. Soc Psychiatry Psychiatr Epidemiol 26, 143–146 (1991). https://doi.org/10.1007/BF00782954
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00782954